PMS64 Comparative Efficacy of Tocilizumab and aTNF Biologic Monotherapies on Patient Reported Outcomes (PROs) in RA Patients Who Have Shown an Inadequate Response to Conventional DMARDs (DMARD-IR)- A Network Meta-Analysis
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1419
https://www.valueinhealthjournal.com/article/S1098-3015(12)03132-4/fulltext
Title :
PMS64 Comparative Efficacy of Tocilizumab and aTNF Biologic Monotherapies on Patient Reported Outcomes (PROs) in RA Patients Who Have Shown an Inadequate Response to Conventional DMARDs (DMARD-IR)- A Network Meta-Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03132-4&doi=10.1016/j.jval.2012.08.1419
First page :
A451
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
916